2.43
-0.07 (-2.8%)
-0.07 (-2.8%)
Upgrade to Real-Time
Regular Market
Low
1.58
High
3.7399
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Entasis Therapeutics Holdings Inc | ETTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.07 | -2.8% | 2.43 | 13:38:41 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.54 | 2.38 | 2.54 | 2.50 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.42 | 2.45 | 0.03 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 455 | 106,176 | $ 2.43 | $ 257,852 | - | 1.58 - 3.7399 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:38:41 | 100 | $ 2.43 | USD |
Period:
Draw Mode:
Entasis Therapeutics Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 114.96M | 47.31M | 27.08M | $ - | $ - | -2.43 | -1.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 20.09M | 0.70% |
Entasis Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ETTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.43 | 2.69 | 2.37 | 2.57 | 152,977 | 0.00 | 0.0% |
| 1 Month | 2.81 | 2.8827 | 2.325 | 2.58 | 148,671 | -0.38 | -13.52% |
| 3 Months | 2.15 | 3.21 | 1.76 | 2.54 | 418,946 | 0.28 | 13.02% |
| 6 Months | 3.45 | 3.6819 | 1.76 | 2.65 | 341,183 | -1.02 | -29.57% |
| 1 Year | 3.07 | 3.7399 | 1.58 | 2.35 | 422,766 | -0.64 | -20.85% |
| 3 Years | 13.45 | 13.70 | 1.58 | 2.84 | 182,714 | -11.02 | -81.93% |
| 5 Years | 13.45 | 13.70 | 1.58 | 2.84 | 182,714 | -11.02 | -81.93% |
Entasis Therapeutics Description
| Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes Zoliflodacin, ETX0282CPDP, and NBP program. |
